UB Paderborn / Katalog / Suche / in CDI

Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial

The lancet oncology, 2019-10, Vol.20 (10), p.1409-1419

2019

Volltextzugriff (PDF)

Greater increases in intratumoral apparent diffusion coefficients after chemoradiotherapy predict better overall survival of patients with cervical cancer

PloS one, 2023-05, Vol.18 (5), p.e0285786-e0285786

2023

Volltextzugriff (PDF)

Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer

BMC cancer, 2019-06, Vol.19 (1), p.584-584, Article 584

2019

Volltextzugriff (PDF)

Dynamic contrast-enhanced perfusion parameters in ovarian cancer: Good accuracy in identifying high HIF-1α expression

PloS one, 2019-08, Vol.14 (8), p.e0221340-e0221340

2019

Volltextzugriff (PDF)

Neoadjuvant chemotherapy induces an elevation of tumour apparent diffusion coefficient values in patients with ovarian cancer

BMC cancer, 2023-04, Vol.23 (1), p.299-299, Article 299

2023

Volltextzugriff (PDF)

Robotic-assisted laparoscopy is a feasible method for resection of deep infiltrating endometriosis, especially in the rectosigmoid area

Journal of international medical research, 2021-08, Vol.49 (8), p.30006052110327-3000605211032788

2021

Volltextzugriff (PDF)

High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer

PloS one, 2020-11, Vol.15 (11), p.e0241484-e0241484

2020

Volltextzugriff (PDF)

Effect of endometriosis on IVF/ICSI outcome: stage III/IV endometriosis worsens cumulative pregnancy and live-born rates

Human reproduction (Oxford), 2005-11, Vol.20 (11), p.3130-3135

2005

Volltextzugriff (PDF)

Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer

BMC cancer, 2014-09, Vol.14 (1), p.696, Article 696

2014

Volltextzugriff (PDF)

Resilience, pain, and health-related quality of life in gynecological patients undergoing surgery for benign and malignant conditions: a 12-month follow-up study

BMC women's health, 2022-08, Vol.22 (1), p.1-345, Article 345

2022

Volltextzugriff (PDF)

Is adaptive treatment planning for single-channel vaginal brachytherapy necessary?

Journal of contemporary brachytherapy, 2021-12, Vol.13 (6), p.687-693

2021

Volltextzugriff (PDF)

The impact of different treatment protocols on achieved radiation doses of high-dose-rate brachytherapy for locally advanced cervical cancer: a comparison between 2 fractions in 1 application and separate applications for each fraction

Journal of contemporary brachytherapy, 2022-10, Vol.14 (5), p.446-451

2022

Volltextzugriff (PDF)

Independent radiologic review of AURELIA, a phase 3 trial of bevacizumab plus chemotherapy for platinum-resistant recurrent ovarian cancer

Gynecologic oncology, 2016-09, Vol.142 (3), p.465-470

2016

Volltextzugriff (PDF)

Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma

BMC cancer, 2010-09, Vol.10 (1), p.512-512, Article 512

2010

Volltextzugriff (PDF)

AAV8-mediated sVEGFR2 and sVEGFR3 gene therapy combined with chemotherapy reduces the growth and microvasculature of human ovarian cancer and prolongs the survival in mice

Frontiers in medicine, 2022-12, Vol.9, p.1018208-1018208

2022

Volltextzugriff (PDF)

Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content

BMC cancer, 2009-05, Vol.9 (1), p.143-143, Article 143

2009

Volltextzugriff (PDF)

High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer

Cancer research (Chicago, Ill.), 2000, Vol.60 (1), p.150-155

2000

Volltextzugriff (PDF)

CD44 Expression Indicates Favorable Prognosis in Epithelial Ovarian Cancer

Clinical cancer research, 2003-11, Vol.9 (14), p.5318-5324

2003

Volltextzugriff (PDF)

Prognostic significance of iNOS in epithelial ovarian cancer

Gynecologic oncology, 2007-04, Vol.105 (1), p.97-103

2007

Volltextzugriff (PDF)

1284: The significance of free hand needles in cervical cancer brachytherapy

Radiotherapy and oncology, 2024-05, Vol.194, p.S251-S254

2024

Volltextzugriff (PDF)

Versican in epithelial ovarian cancer: Relation to hyaluronan, clinicopathologic factors and prognosis

International journal of cancer, 2003-11, Vol.107 (3), p.359-364

2003

Volltextzugriff (PDF)

Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression

BMC cancer, 2009-08, Vol.9 (1), p.289-289, Article 289

2009

Volltextzugriff (PDF)

Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas

International journal of cancer, 2006-09, Vol.119 (6), p.1345-1353

2006

Volltextzugriff (PDF)

Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p

International journal of cancer, 2004-03, Vol.109 (2), p.247-252

2004

Volltextzugriff (PDF)

MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study

The lancet oncology, 2021-04, Vol.22 (4), p.538-547

2021

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial

Greater increases in intratumoral apparent diffusion coefficients after chemoradiotherapy predict better overall survival of patients with cervical cancer

Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer

Dynamic contrast-enhanced perfusion parameters in ovarian cancer: Good accuracy in identifying high HIF-1α expression

Neoadjuvant chemotherapy induces an elevation of tumour apparent diffusion coefficient values in patients with ovarian cancer

Robotic-assisted laparoscopy is a feasible method for resection of deep infiltrating endometriosis, especially in the rectosigmoid area

High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer

Effect of endometriosis on IVF/ICSI outcome: stage III/IV endometriosis worsens cumulative pregnancy and live-born rates

Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer

Resilience, pain, and health-related quality of life in gynecological patients undergoing surgery for benign and malignant conditions: a 12-month follow-up study

Is adaptive treatment planning for single-channel vaginal brachytherapy necessary?

The impact of different treatment protocols on achieved radiation doses of high-dose-rate brachytherapy for locally advanced cervical cancer: a comparison between 2 fractions in 1 application and separate applications for each fraction

Independent radiologic review of AURELIA, a phase 3 trial of bevacizumab plus chemotherapy for platinum-resistant recurrent ovarian cancer

Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma

AAV8-mediated sVEGFR2 and sVEGFR3 gene therapy combined with chemotherapy reduces the growth and microvasculature of human ovarian cancer and prolongs the survival in mice

Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content

High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer

CD44 Expression Indicates Favorable Prognosis in Epithelial Ovarian Cancer

Prognostic significance of iNOS in epithelial ovarian cancer

1284: The significance of free hand needles in cervical cancer brachytherapy

Versican in epithelial ovarian cancer: Relation to hyaluronan, clinicopathologic factors and prognosis

Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression

Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas

Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p

MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study

Suchergebnisse filtern